Artesunate and sorafenib: Combinatorial inhibition of liver cancer cell growth

An antimalarial medication, artesunate (Art), has exhibited promising anticancer effects with excellent tolerability in various types of cancer, suggesting that it has the potential to be used in combination with sorafenib (Sora) in hepatocellular carcinoma (HCC) treatment. To determine the potency...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hao, Xu, Kanghe, Pian, Guangzhe, Sun, Shu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781774/
https://www.ncbi.nlm.nih.gov/pubmed/31611983
http://dx.doi.org/10.3892/ol.2019.10810

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781774/
https://www.ncbi.nlm.nih.gov/pubmed/31611983
http://dx.doi.org/10.3892/ol.2019.10810

Ejemplares similares